Report Detail

Other Global Integrated Drug Discovery Service Market Growth (Status and Outlook) 2022-2028

  • RnM4495232
  • |
  • 10 November, 2022
  • |
  • Global
  • |
  • 123 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

The global market for Integrated Drug Discovery Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Integrated Drug Discovery Service players cover Syngene, Eurofins, Charles River, Evotec and BioAscent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Integrated Drug Discovery Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Integrated Drug Discovery Service market, with both quantitative and qualitative data, to help readers understand how the Integrated Drug Discovery Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Integrated Drug Discovery Service market and forecasts the market size by Type (Ligand Based Drug Discovery, Structure Based Drug Discovery and Others), by Application (Biotech and Pharmaceutical Companies, Academic Institution and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Ligand Based Drug Discovery
Structure Based Drug Discovery
Others

Segmentation by application
Biotech and Pharmaceutical Companies
Academic Institution
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Syngene
Eurofins
Charles River
Evotec
BioAscent
Sygnature Discovery
Jubilant Biosys
Charnwood Molecular
Domainex
Pharmaron
Dalton Pharma Services
Selvita
Metrion Biosciences
WuXi AppTec
Malvern Panalytical
Hitgen
BioDuro
Curia Global
Taros Chemicals
Symeres
Aragen Life Sciences

Chapter Introduction
Chapter 1: Scope of Integrated Drug Discovery Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Integrated Drug Discovery Service market size and CAGR, Integrated Drug Discovery Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Integrated Drug Discovery Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Integrated Drug Discovery Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Integrated Drug Discovery Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Syngene, Eurofins, Charles River, Evotec, BioAscent, Sygnature Discovery, Jubilant Biosys, Charnwood Molecular and Domainex, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Integrated Drug Discovery Service Market Size 2017-2028
    • 2.1.2 Integrated Drug Discovery Service Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Integrated Drug Discovery Service Segment by Type
    • 2.2.1 Ligand Based Drug Discovery
    • 2.2.2 Structure Based Drug Discovery
    • 2.2.3 Others
  • 2.3 Integrated Drug Discovery Service Market Size by Type
    • 2.3.1 Integrated Drug Discovery Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Integrated Drug Discovery Service Market Size Market Share by Type (2017-2022)
  • 2.4 Integrated Drug Discovery Service Segment by Application
    • 2.4.1 Biotech and Pharmaceutical Companies
    • 2.4.2 Academic Institution
    • 2.4.3 Others
  • 2.5 Integrated Drug Discovery Service Market Size by Application
    • 2.5.1 Integrated Drug Discovery Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Integrated Drug Discovery Service Market Size Market Share by Application (2017-2022)

3 Integrated Drug Discovery Service Market Size by Player

  • 3.1 Integrated Drug Discovery Service Market Size Market Share by Players
    • 3.1.1 Global Integrated Drug Discovery Service Revenue by Players (2020-2022)
    • 3.1.2 Global Integrated Drug Discovery Service Revenue Market Share by Players (2020-2022)
  • 3.2 Global Integrated Drug Discovery Service Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Integrated Drug Discovery Service by Regions

  • 4.1 Integrated Drug Discovery Service Market Size by Regions (2017-2022)
  • 4.2 Americas Integrated Drug Discovery Service Market Size Growth (2017-2022)
  • 4.3 APAC Integrated Drug Discovery Service Market Size Growth (2017-2022)
  • 4.4 Europe Integrated Drug Discovery Service Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Integrated Drug Discovery Service Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Integrated Drug Discovery Service Market Size by Country (2017-2022)
  • 5.2 Americas Integrated Drug Discovery Service Market Size by Type (2017-2022)
  • 5.3 Americas Integrated Drug Discovery Service Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Integrated Drug Discovery Service Market Size by Region (2017-2022)
  • 6.2 APAC Integrated Drug Discovery Service Market Size by Type (2017-2022)
  • 6.3 APAC Integrated Drug Discovery Service Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Integrated Drug Discovery Service by Country (2017-2022)
  • 7.2 Europe Integrated Drug Discovery Service Market Size by Type (2017-2022)
  • 7.3 Europe Integrated Drug Discovery Service Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Integrated Drug Discovery Service by Region (2017-2022)
  • 8.2 Middle East & Africa Integrated Drug Discovery Service Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Integrated Drug Discovery Service Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Integrated Drug Discovery Service Market Forecast

  • 10.1 Global Integrated Drug Discovery Service Forecast by Regions (2023-2028)
    • 10.1.1 Global Integrated Drug Discovery Service Forecast by Regions (2023-2028)
    • 10.1.2 Americas Integrated Drug Discovery Service Forecast
    • 10.1.3 APAC Integrated Drug Discovery Service Forecast
    • 10.1.4 Europe Integrated Drug Discovery Service Forecast
    • 10.1.5 Middle East & Africa Integrated Drug Discovery Service Forecast
  • 10.2 Americas Integrated Drug Discovery Service Forecast by Country (2023-2028)
    • 10.2.1 United States Integrated Drug Discovery Service Market Forecast
    • 10.2.2 Canada Integrated Drug Discovery Service Market Forecast
    • 10.2.3 Mexico Integrated Drug Discovery Service Market Forecast
    • 10.2.4 Brazil Integrated Drug Discovery Service Market Forecast
  • 10.3 APAC Integrated Drug Discovery Service Forecast by Region (2023-2028)
    • 10.3.1 China Integrated Drug Discovery Service Market Forecast
    • 10.3.2 Japan Integrated Drug Discovery Service Market Forecast
    • 10.3.3 Korea Integrated Drug Discovery Service Market Forecast
    • 10.3.4 Southeast Asia Integrated Drug Discovery Service Market Forecast
    • 10.3.5 India Integrated Drug Discovery Service Market Forecast
    • 10.3.6 Australia Integrated Drug Discovery Service Market Forecast
  • 10.4 Europe Integrated Drug Discovery Service Forecast by Country (2023-2028)
    • 10.4.1 Germany Integrated Drug Discovery Service Market Forecast
    • 10.4.2 France Integrated Drug Discovery Service Market Forecast
    • 10.4.3 UK Integrated Drug Discovery Service Market Forecast
    • 10.4.4 Italy Integrated Drug Discovery Service Market Forecast
    • 10.4.5 Russia Integrated Drug Discovery Service Market Forecast
  • 10.5 Middle East & Africa Integrated Drug Discovery Service Forecast by Region (2023-2028)
    • 10.5.1 Egypt Integrated Drug Discovery Service Market Forecast
    • 10.5.2 South Africa Integrated Drug Discovery Service Market Forecast
    • 10.5.3 Israel Integrated Drug Discovery Service Market Forecast
    • 10.5.4 Turkey Integrated Drug Discovery Service Market Forecast
    • 10.5.5 GCC Countries Integrated Drug Discovery Service Market Forecast
  • 10.6 Global Integrated Drug Discovery Service Forecast by Type (2023-2028)
  • 10.7 Global Integrated Drug Discovery Service Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Syngene
    • 11.1.1 Syngene Company Information
    • 11.1.2 Syngene Integrated Drug Discovery Service Product Offered
    • 11.1.3 Syngene Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Syngene Main Business Overview
    • 11.1.5 Syngene Latest Developments
  • 11.2 Eurofins
    • 11.2.1 Eurofins Company Information
    • 11.2.2 Eurofins Integrated Drug Discovery Service Product Offered
    • 11.2.3 Eurofins Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Eurofins Main Business Overview
    • 11.2.5 Eurofins Latest Developments
  • 11.3 Charles River
    • 11.3.1 Charles River Company Information
    • 11.3.2 Charles River Integrated Drug Discovery Service Product Offered
    • 11.3.3 Charles River Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Charles River Main Business Overview
    • 11.3.5 Charles River Latest Developments
  • 11.4 Evotec
    • 11.4.1 Evotec Company Information
    • 11.4.2 Evotec Integrated Drug Discovery Service Product Offered
    • 11.4.3 Evotec Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Evotec Main Business Overview
    • 11.4.5 Evotec Latest Developments
  • 11.5 BioAscent
    • 11.5.1 BioAscent Company Information
    • 11.5.2 BioAscent Integrated Drug Discovery Service Product Offered
    • 11.5.3 BioAscent Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 BioAscent Main Business Overview
    • 11.5.5 BioAscent Latest Developments
  • 11.6 Sygnature Discovery
    • 11.6.1 Sygnature Discovery Company Information
    • 11.6.2 Sygnature Discovery Integrated Drug Discovery Service Product Offered
    • 11.6.3 Sygnature Discovery Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Sygnature Discovery Main Business Overview
    • 11.6.5 Sygnature Discovery Latest Developments
  • 11.7 Jubilant Biosys
    • 11.7.1 Jubilant Biosys Company Information
    • 11.7.2 Jubilant Biosys Integrated Drug Discovery Service Product Offered
    • 11.7.3 Jubilant Biosys Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Jubilant Biosys Main Business Overview
    • 11.7.5 Jubilant Biosys Latest Developments
  • 11.8 Charnwood Molecular
    • 11.8.1 Charnwood Molecular Company Information
    • 11.8.2 Charnwood Molecular Integrated Drug Discovery Service Product Offered
    • 11.8.3 Charnwood Molecular Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Charnwood Molecular Main Business Overview
    • 11.8.5 Charnwood Molecular Latest Developments
  • 11.9 Domainex
    • 11.9.1 Domainex Company Information
    • 11.9.2 Domainex Integrated Drug Discovery Service Product Offered
    • 11.9.3 Domainex Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Domainex Main Business Overview
    • 11.9.5 Domainex Latest Developments
  • 11.10 Pharmaron
    • 11.10.1 Pharmaron Company Information
    • 11.10.2 Pharmaron Integrated Drug Discovery Service Product Offered
    • 11.10.3 Pharmaron Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Pharmaron Main Business Overview
    • 11.10.5 Pharmaron Latest Developments
  • 11.11 Dalton Pharma Services
    • 11.11.1 Dalton Pharma Services Company Information
    • 11.11.2 Dalton Pharma Services Integrated Drug Discovery Service Product Offered
    • 11.11.3 Dalton Pharma Services Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Dalton Pharma Services Main Business Overview
    • 11.11.5 Dalton Pharma Services Latest Developments
  • 11.12 Selvita
    • 11.12.1 Selvita Company Information
    • 11.12.2 Selvita Integrated Drug Discovery Service Product Offered
    • 11.12.3 Selvita Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Selvita Main Business Overview
    • 11.12.5 Selvita Latest Developments
  • 11.13 Metrion Biosciences
    • 11.13.1 Metrion Biosciences Company Information
    • 11.13.2 Metrion Biosciences Integrated Drug Discovery Service Product Offered
    • 11.13.3 Metrion Biosciences Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Metrion Biosciences Main Business Overview
    • 11.13.5 Metrion Biosciences Latest Developments
  • 11.14 WuXi AppTec
    • 11.14.1 WuXi AppTec Company Information
    • 11.14.2 WuXi AppTec Integrated Drug Discovery Service Product Offered
    • 11.14.3 WuXi AppTec Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 WuXi AppTec Main Business Overview
    • 11.14.5 WuXi AppTec Latest Developments
  • 11.15 Malvern Panalytical
    • 11.15.1 Malvern Panalytical Company Information
    • 11.15.2 Malvern Panalytical Integrated Drug Discovery Service Product Offered
    • 11.15.3 Malvern Panalytical Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Malvern Panalytical Main Business Overview
    • 11.15.5 Malvern Panalytical Latest Developments
  • 11.16 Hitgen
    • 11.16.1 Hitgen Company Information
    • 11.16.2 Hitgen Integrated Drug Discovery Service Product Offered
    • 11.16.3 Hitgen Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Hitgen Main Business Overview
    • 11.16.5 Hitgen Latest Developments
  • 11.17 BioDuro
    • 11.17.1 BioDuro Company Information
    • 11.17.2 BioDuro Integrated Drug Discovery Service Product Offered
    • 11.17.3 BioDuro Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 BioDuro Main Business Overview
    • 11.17.5 BioDuro Latest Developments
  • 11.18 Curia Global
    • 11.18.1 Curia Global Company Information
    • 11.18.2 Curia Global Integrated Drug Discovery Service Product Offered
    • 11.18.3 Curia Global Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Curia Global Main Business Overview
    • 11.18.5 Curia Global Latest Developments
  • 11.19 Taros Chemicals
    • 11.19.1 Taros Chemicals Company Information
    • 11.19.2 Taros Chemicals Integrated Drug Discovery Service Product Offered
    • 11.19.3 Taros Chemicals Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 Taros Chemicals Main Business Overview
    • 11.19.5 Taros Chemicals Latest Developments
  • 11.20 Symeres
    • 11.20.1 Symeres Company Information
    • 11.20.2 Symeres Integrated Drug Discovery Service Product Offered
    • 11.20.3 Symeres Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 Symeres Main Business Overview
    • 11.20.5 Symeres Latest Developments
  • 11.21 Aragen Life Sciences
    • 11.21.1 Aragen Life Sciences Company Information
    • 11.21.2 Aragen Life Sciences Integrated Drug Discovery Service Product Offered
    • 11.21.3 Aragen Life Sciences Integrated Drug Discovery Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.21.4 Aragen Life Sciences Main Business Overview
    • 11.21.5 Aragen Life Sciences Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Integrated Drug Discovery Service. Industry analysis & Market Report on Integrated Drug Discovery Service is a syndicated market report, published as Global Integrated Drug Discovery Service Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Integrated Drug Discovery Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,045.12
6,090.24
3,524.58
7,049.16
506,031.60
1,012,063.20
297,484.80
594,969.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report